0.78 USD
↘ 0.07 (8.42%)AT CLOSE (11:59 AM EDT)
KALA BIO, Inc. Common Stock
KALANASDAQ • USD
0.80
↗ 0.03 (3.25%)
POST MARKET (AS OF 07:56 PM EDT)
Post Market
AS OF 07:56 PM EDT
0.80
↗ 0.03 (3.25%)
Market: CLOSED
KALA is currently priced at $0.77. The stock presents a bearish profile across the board: technical indicators signal "Strong Sell" and our fundamental models agree with a "Sell" rating. Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On the valuation side, KALA appears attractively valued relative to sector peers across key multiples.
Technical & fundamental data as of Jul 17, 2026.
Open?$0.91
High?$0.91
Low?$0.76
Prev. Close?$0.85
Volume?188.3K
Avg. Volume?188.4K
VWAP?$0.81
Rel. Volume?1.00x
Bid / Ask
Bid?$0.67 × 100
Ask?$3.87 × 100
Spread?$3.20
Midpoint?$2.27
Valuation & Ratios
Market Cap?15.8M
Shares Out?18.6M
Float?796.5M
Float %?83.4%
P/E Ratio?N/A
P/B Ratio?1.47
EPS?-$1.06
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Kala Bio Inc is a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of inventive therapies for rare and severe diseases of the front and back of the eye. It main product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.
Address
1167 MASSACHUSETTS AVENUE
ARLINGTON, MA 02476
Phone: 781-996-5252
ARLINGTON, MA 02476
Phone: 781-996-5252
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?50
Short Sent.?80
Piotroski F-Score?0/9Weak
Altman Z-Score?-80.14Distress
Confidence?40%Low
Short InterestLow
Short % of Float?0.03%Low
Short Interest?218.5K
Days to Cover?1.0
Free Float796.5M
Avg Daily Volume213.6K
Settlement Date2026-06-30
Financial Health
Current Ratio?7.91Strong
Quick Ratio?7.91Strong
Cash Ratio?1.13Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?1.47CHEAP▾
Peers100
S&P88
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-0.5CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-182.6%WEAK▾
S&P3
ROA?-159.6%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-26077000
Enterprise Value?$14.0M
Fundamentals ratios updated end of day